A multicenter, randomized, double-blind, placebo-controlled, dose-tolerability titration study to evaluate the efficacy and safety of perampanel (E2007) in patients with post-herpetic neuralgia (PHN).

Trial Profile

A multicenter, randomized, double-blind, placebo-controlled, dose-tolerability titration study to evaluate the efficacy and safety of perampanel (E2007) in patients with post-herpetic neuralgia (PHN).

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Feb 2013

At a glance

  • Drugs Perampanel (Primary)
  • Indications Postherpetic neuralgia
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 May 2012 Actual patient number added 135 according to ClinicalTrials.gov.
    • 12 Aug 2009 Additional location identified as reported by ClinicalTrials.gov.
    • 12 Aug 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top